Clinical trials
Phase 2 Squamous Cell Carcinoma of Head and Neck trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 12 |
| 2022 | 2 |
| 2023 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 66 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 4 |
| Xuekui Liu | 3 |
| Chinese Academy of Medical Sciences | 2 |
| First Affiliated Hospital of Zhejiang University | 2 |
| ISA Pharmaceuticals | 2 |
| Peking Union Medical College Hospital | 2 |
| Radboud University Medical Center | 2 |
| Shi Yuankai | 2 |
| Sinocelltech Ltd. | 2 |
| Sun Yat-sen University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 66 |
| Head and Neck Neoplasms | 15 |
| Salivary Gland Neoplasms | 3 |
| Tongue Neoplasms | 3 |
| Hypopharyngeal Neoplasms | 2 |
| Mouth Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Recurrence | 2 |
| Adenocarcinoma, Follicular | 1 |
| Adrenocortical Carcinoma | 1 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.